Direct arginine modification in native peptides and application to chemical probe development
Lab / animal
OA: closed
AI-generated summary
This paper reports a method for directly labeling the arginine guanidinium group in native peptides under mild conditions, demonstrating its utility for modifying leuprolide and microcystin.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
An efficient method for the direct labeling of the Arg guanidinium group in native peptides is reported. This straightforward procedure allows modifying the arginine moiety in peptides with various reporter groups, such as fluorophores, biotin, etc., under mild conditions in an operationally simple procedure. The scope of this method tolerates various functionalized amino acids such as His, Ser, Trp, Tyr, Glu, etc., while the only limitations uncovered so far are restricted to cysteine and free amine residues. The utility of this late-stage diversification method was demonstrated in direct labeling of leuprolide, a clinically used drug, for distribution monitoring in Daphnia, and in labeling of microcystin, a cyanobacterial toxin.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-10-25T09:32:14.900964+00:00
- pubmed
- last seen: 2026-10-08T21:14:48.268335+00:00